Eli Lilly
LLY
LLY
2,601 hedge funds and large institutions have $270B invested in Eli Lilly in 2023 Q1 according to their latest regulatory filings, with 152 funds opening new positions, 1,059 increasing their positions, 995 reducing their positions, and 153 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 2,659 → 2,601 (-58)
6% less capital invested
Capital invested by funds: $288B → $270B (-$18.6B)
23% less funds holding in top 10
Funds holding in top 10: 197 → 151 (-46)
Holders
2,601
Holding in Top 10
151
Calls
$2.16B
Puts
$2.03B
Top Buyers
| 1 | +$882M | |
| 2 | +$729M | |
| 3 | +$456M | |
| 4 |
Amundi
Paris,
France
|
+$405M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$356M |
Top Sellers
| 1 | -$1.75B | |
| 2 | -$1.6B | |
| 3 | -$1.18B | |
| 4 |
Jennison Associates
New York
|
-$637M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$592M |